This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Myriad Genetics Q4 2025 Earnings Call
Business Earnings call

Myriad Genetics Q4 2025 Earnings Call

Analysis based on 7 articles · First reported Feb 16, 2026 · Last updated Feb 16, 2026

Sentiment
0
Attention
2
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The market will be impacted by the financial overview and business update provided by Myriad Genetics during its earnings call. Investor conferences will also offer opportunities for Myriad Genetics to engage with the market, potentially influencing investor sentiment.

Biotechnology Healthcare
Event Summary

Myriad Genetics, a leader in molecular testing and precision medicine, will hold its fourth quarter and full year 2025 earnings conference call on Monday, Feb. 23, 2026. The company's quarterly earnings will be released after the market closes on the same day. During the call, Myriad Genetics management will provide a financial overview and business update. Additionally, Sam Raha, President and CEO, and Ben Wheeler, Chief Financial Officer, will participate in three upcoming investor healthcare conferences: the Toronto-Dominion Bank===TD Cowen 46th Annual Health Care Conference, the SVB Financial Group===Leerink Partners Global Healthcare Conference, and the Barclays 28th Annual Global Healthcare conference.

Key Actions
90 Myriad Genetics will hold earnings conference call
90 Myriad Genetics will release quarterly earnings
70 Sam Raha will participate in investor healthcare conferences
70 Ben Wheeler will participate in investor healthcare conferences
Entities Involved
stock
Myriad Genetics
Myriad Genetics will hold its fourth quarter and full year 2025 earnings conference call, providing a financial overview and business update. This event is a routine disclosure for Myriad Genetics, offering transparency to investors.
Importance 100 Sentiment 0
per
Sam Raha
Sam Raha, President and CEO of Myriad Genetics, will participate in investor healthcare conferences, representing Myriad Genetics and providing insights into the company's performance and future outlook.
Importance 60 Sentiment 0
per
Ben Wheeler
Ben Wheeler, Chief Financial Officer of Myriad Genetics, will participate in investor healthcare conferences alongside Sam Raha, offering financial details and updates on Myriad Genetics.
Importance 60 Sentiment 0
subs
Toronto-Dominion Bank===TD Cowen
Toronto-Dominion Bank===TD Cowen is hosting its 46th Annual Health Care Conference, where Myriad Genetics management will participate in a fireside chat.
Importance 20 Sentiment 0
subs
SVB Financial Group===Leerink Partners
SVB Financial Group===Leerink Partners is hosting its Global Healthcare Conference, where Myriad Genetics management will participate in a fireside chat.
Importance 20 Sentiment 0
stock
Barclays
Barclays is hosting its 28th Annual Global Healthcare conference, where Myriad Genetics management will participate in 1-on-1 meetings.
Importance 20 Sentiment 0
Relationships
Sam Raha related ↔ Myriad Genetics
Ben Wheeler related ↔ Myriad Genetics
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.